pimozide has been researched along with ALS - Amyotrophic Lateral Sclerosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggad, D; Armstrong, GA; Ciura, S; Drapeau, P; Ichida, J; Julien, JP; Kabashi, E; Korngut, L; La Fontaine, A; Liao, M; Maios, C; Martinez, J; Parker, JA; Patten, SA; Petrillo, J; Rafuse, V; Robitaille, R; Tremblay, E; Wen, XY; Zinman, L | 1 |
| Kuehn, BM | 1 |
| Julien, JP; Pozzi, S; Thammisetty, SS | 1 |
| Borchelt, DR; Wymer, J | 1 |
| Armstrong, GAB; Barden, C; Bose, P; Drapeau, P; Liao, M; Maios, C; Narasimhan, V; Parker, JA; Robitaille, R; Tremblay, E; Wen, XY | 1 |
1 trial(s) available for pimozide and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antipsychotic Agents; Caenorhabditis elegans; Calcium Channels; Calcium Channels, T-Type; Disease Models, Animal; DNA-Binding Proteins; Drug Evaluation, Preclinical; Drug Tolerance; Female; Mice; Neuromuscular Junction; Neuromuscular Junction Diseases; Pimozide; Zebrafish; Zebrafish Proteins | 2017 |
4 other study(ies) available for pimozide and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Simple Models and Ice Bucket Challenge Fuel Progress in ALS Treatment.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antipsychotic Agents; Caenorhabditis elegans; Clinical Trials, Phase II as Topic; Disease Models, Animal; Fund Raising; Humans; Neuromuscular Junction; Pimozide; Research Support as Topic; Social Media | 2018 |
Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis.
Topics: Age Factors; Amyotrophic Lateral Sclerosis; Animals; Anti-Dyskinesia Agents; Body Weight; Botulinum Toxins, Type A; Disease Models, Animal; DNA-Binding Proteins; Female; Humans; Male; Mice; Mice, Transgenic; Motor Activity; Movement Disorders; Muscle Strength; Mutation; Neuromuscular Agents; Neuromuscular Junction; Phosphopyruvate Hydratase; Pimozide; Statistics, Nonparametric; Superoxide Dismutase | 2018 |
Targeting the Neuromuscular Junction in ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Mice; Motor Neurons; Neuromuscular Junction; Pimozide | 2018 |
The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; C9orf72 Protein; Caenorhabditis elegans; Disease Models, Animal; DNA-Binding Proteins; Humans; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuromuscular Junction; Organ Culture Techniques; Pimozide; Superoxide Dismutase-1; Zebrafish | 2019 |